Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults

Benzodiazepine receptor agonists (BZRAs) are sedative-hypnotic drugs that are often used to treat anxiety and panic disorders, sleeping problems (insomnia), seizures and alcohol withdrawal. These medications can lead to dependency and cause side effects including fatigue, impaired balance and falls, memory problems, and problems holding urine. Their use has been associated with a higher risk of motor vehicle collisions.

Despite agreement that BZRAs should be avoided whenever possible in older adults, these medications continue to be frequently prescribed. Recent Canadian data suggest high rates of use persist among older adults, especially females, with 18.7% of females reporting past-year use (Statistics Canada, 2016).

The goal of CCSMH’s Canadian Guidelines on BZRA Use Disorder Among Older Adults is to provide guidance for clinicians on preventing the development of BZRA Use Disorder or assessing and treating older individuals who have developed such a disorder.

CCSMH Webinar: Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults

This presentation summarizes CCSMH’s Clinical Guidelines on Benzodiazepine Receptor Agonist Use Disorder (BUD) Among Older Adults. The session provides guidance for clinicians on preventing the development of a BUD, optimally assessing and treating older individuals who have developed such a disorder.

Click here to access the webinar recording.